Your browser doesn't support javascript.
loading
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
Markmann, Alena J; Giallourou, Natasa; Bhowmik, D Ryan; Hou, Yixuan J; Lerner, Aaron; Martinez, David R; Premkumar, Lakshmanane; Root, Heather; van Duin, David; Napravnik, Sonia; Graham, Stephen D; Guerra, Quique; Raut, Rajendra; Petropoulos, Christos J; Wrin, Terri; Cornaby, Caleb; Schmitz, John; Kuruc, JoAnn; Weiss, Susan; Park, Yara; Baric, Ralph; de Silva, Aravinda M; Margolis, David M; Bartelt, Luther A.
Afiliação
  • Markmann AJ; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Giallourou N; Centre of Excellence in Biobanking and Biomedical Research, Molecular Medicine Research Center, University of Cyprus, Nicosia, Cyprus.
  • Bhowmik DR; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Lerner A; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Premkumar L; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Root H; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • van Duin D; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Napravnik S; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Graham SD; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Guerra Q; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Raut R; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Petropoulos CJ; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Wrin T; LabCorp-Monogram Biosciences, South San Francisco, California, USA.
  • Cornaby C; LabCorp-Monogram Biosciences, South San Francisco, California, USA.
  • Schmitz J; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Kuruc J; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Weiss S; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Park Y; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Baric R; UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • de Silva AM; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Margolis DM; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Bartelt LA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
mSphere ; 6(4): e0027521, 2021 08 25.
Article em En | MEDLINE | ID: mdl-34431693

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article